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A B S T R A C T
Objective: To explore the risk factors for ectopic pregnancy (EP) in women with planned pregnancy.
Study design: This case–control study was conducted in women with planned pregnancy and included
900 women diagnosed with EP (case group) and 889 women with intrauterine pregnancy (IUP) as the
control group matched in terms of age and gestational week. Socio-demographic characteristics,
reproductive history, gynecological and surgical history, previous contraceptive use, and history of
infertility were compared between the two groups. Blood samples were collected from all the
participants to detect serum chlamydia trachomatis (CT) IgG antibody. The odds ratio (OR) with its 95%
conﬁdential interval (CI) of each variable was calculated by univariable conditional logistic regression
analysis. Factors signiﬁcantly different between both groups, as revealed by univariable analysis, were
entered into a multivariable logistic regression model by stepwise selection.
Results: The risk of EP was associated with previous adnexal surgery (adjusted OR = 3.99, 95% CI: 2.40–
6.63), uncertainty of previous pelvic inﬂammatory disease (adjusted OR = 6.89, 95% CI: 3.29–14.41), and
positive CT IgG serology (adjusted OR = 5.26, 95% CI: 3.94–7.04). A history of infertility including tubal
infertility (adjusted OR = 3.62, 95% CI: 1.52–8.63), non-tubal infertility (adjusted OR = 3.34, 95% CI: 1.60–
6.93), and in vitro fertilization (IVF) treatment (adjusted OR = 5.96, 95% CI: 1.68–21.21) were correlated
with the risk of EP. Women who had previously used condoms were less likely to have EP during the
current cycle (adjusted OR = 0.27, 95% CI: 0.21–0.36).
Conclusions: Besides well-acknowledged risk factors for EP, attention should be paid to women with
planned pregnancy who have a history of infertility and/or IVF treatment, to prevent complications
from EP.
 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Ectopic pregnancy (EP) is the leading cause of maternal
mortality in the ﬁrst trimester of pregnancy [1]. Approximately
1–2% of all naturally conceived pregnancies end up with EP [2]. In
the past decades, the occurrence of EP has been on the rise in many
countries [3,4].* Corresponding author at: Department of Obstetrics and Gynecology, Interna-
tional Peace Maternity and Child Health Hospital, School of Medicine, Shanghai
Jiaotong University, 910 Hengshan Road, Shanghai 200030, People’s Republic of
China. Tel.: +86 21 64070434; fax: +86 21 64073896.
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0301-2115/ 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
nd/3.0/).In the general female population, the widely accepted risk
factors for EP include tubal damage resulting from pelvic infection
(e.g. chlamydia trachomatis, CT) or previous adnexal surgery,
smoking, and in vitro fertilization (IVF) [2,5]. These risk factors are
not necessarily independent of one another, and the risk of EP
varies among different populations [5]. Fertility intention might
have an impact on pregnancy outcome [6]. Women not planning to
become pregnant often resort to a variety of contraceptive
methods, most of which could prevent unwanted pregnancy
(intrauterine or ectopic), but if contraception fails, some con-
traceptive methods, like intrauterine device (IUD) and oral
contraceptive pills (OCPs), could potentially increase the EP risk
according to the results of a meta-analysis [7]. Women with
planned pregnancy include a certain population of females with a
history of infertility and/or assisted reproduction technologiesarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
Fig. 1. Recruitment proﬁle of the study.
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with planned pregnancy from those in the general female
population has not been determined. We therefore conducted
this case control study to explore the risk factors for EP in women
with planned pregnancy.Table 1
Sociodemographic characteristics of women with planned pregnancy (ectopic vs. intra
EP IUP 
na (%) na (%)
Age (year) 
19 (youngest 17) 1 (0.11) 1 (0.11) 
20–29 446 (49.56) 481 (54.11) 
30–39 441 (49.00) 396 (44.54) 
40 (eldest 43) 12 (1.33) 11 (1.24) 
Marital status 
Married 872 (96.89) 862 (96.96) 
Unmarried 28 (3.11) 27 (3.04) 
Educational attainment 
University or above 467 (52.53) 612 (68.84) 
High school 107 (12.04) 92 (10.35) 
Middle school 66 (7.42) 54 (6.07) 
Primary school or lower 260 (29.25) 131 (14.74) 
Occupation 
Employed 627 (69.90) 729 (82.09) 
Self-employed 106 (11.82) 61 (6.87) 
Unemployed 164 (18.28) 98 (11.04) 
Individual annual income (¥) 
>100,000 244 (27.70) 270 (30.44) 
50,000–100,000 237 (26.90) 330 (37.20) 
<50,000 400 (45.40) 287 (32.36) 
Active tobacco smokerc
Never 815 (92.30) 838 (95.77) 
Lighter smoker 49 (5.55) 30 (3.34) 
Heavy smoker 19 (2.15) 7 (0.80) 
Exposure to passive smokingc
Never 504 (56.88) 611 (69.27) 
Occasionally 29 (3.27) 22 (2.49) 
Frequently 353 (39.84) 249 (28.23) 
EP: ectopic pregnancy; IUP: intrauterine pregnancy; OR: odds ratio; CI: conﬁdence int
a The sum does not necessarily equal the sample size for all the variables because of mi
cases and 2 in controls; active tobacco smoker: 17 in cases and 14 in controls; exposu
b The p value of the test for trend is given.
c Light smoker and occasional exposure to passive smoking: smoking less than 1 cigare
than 1 cigarette per day for a minimum of 6 months.Materials and methods
Ethical considerations
This study was approved by Institutional Review Board and was
conducted at the International Peace Maternity and Child Health
Hospital in Shanghai, China. Written informed consent was
obtained from women before recruitment.
Participants and methods
The study was conducted during a period from September 2010
to April 2013. According to the American College of Obstetricians
and Gynecologists Practice Bulletin [8], the diagnosis and location
of pregnancy were conﬁrmed at operation for EP patients who
received surgical treatment. The EP diagnosis was conﬁrmed by a
combination of tests, including serum b-hCG level and transvagi-
nal ultrasonography, for patients who received medical treatment.
All the women diagnosed with EP by the uniﬁed diagnosis criteria
at our prenatal care center were asked if their pregnancies were
planned. Women with planned pregnancy were then recruited into
the case group (EP group). During the same study period, women
presenting at our prenatal care center with planned intrauterine
pregnancy (IUP) were recruited as the control group (IUP group).
The two groups were matched in terms of age (5 years) and
gestational age (7 days).
An investigator who was blind to the group of participants
was responsible for data collection by questionnaire. To ensure a
high completion rate, the questionnaire was ﬁlled out by the
investigator during interview. The information collected for
each participant included sociodemographic characteristics,uterine).
OR 95% CI p-Value
0.29
1.08 [0.07, 17.29]
Reference
1.20 [0.99, 1.45]
1.18 [0.51, 2.69]
0.93
Reference
1.03 [0.60, 1.75]
<103 b
Reference
1.52 [1.12, 2.07]
1.60 [1.10, 2.34]
2.60 [2.04, 3.31]
<103
Reference
2.02 [1.45, 2.82]
1.95 [1.48, 2.55]
<103 b
Reference
0.80 [0.63, 1.01]
1.54 [1.23, 1.94]
<103 b
Reference
1.68 [1.06, 2.67]
2.79 [1.17, 6.67]
<103 b
Reference
1.60 [0.91, 2.82]
1.72 [1.41, 2.10]
erval.
ssing data (occupation: 3 in cases and 1 in controls; individual annual income: 19 in
re to passive smoking: 14 in cases and 7 in controls).
tte per day; heavy smoker and frequent exposure to passive smoking; smoking more
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previous contraceptive use and a history of infertility.
Blood from each participant was taken for detection of serum
CT IgG antibody by applying the enzyme-linked immunosorbent
assay (ELISA; Beijing Biosynthesis Biotechnology, China) according
to the instructions.
Statistical analysis
Data were analyzed by Statistical Analysis System Software
(Version 8.2, SAS Institute Inc., Cary, NC, USA). We used a
statistical power of 80% to detect a difference in both groups at
an a level of 0.05. The chi-square test or Cochran–ArmitageTable 2
History of reproduction, gynecology, and surgery in women with planned pregnancy (
EP IUP 
na (%) na (%)
Reproductive history
Parity 
0 672 (77.42) 673 (7
1 179 (20.62) 205 (2
2 17 (1.96) 11 (1
Number of previous abortions 
0 317 (36.52) 469 (5
1 261 (30.07) 271 (3
2 176 (20.28) 107 (1
3 114 (13.13) 42 (4
Spontaneous abortion 
No 766 (88.25) 818 (9
Yes 102 (11.75) 71 (7
Medical abortion 
No 739 (85.14) 789 (8
Yes 129 (14.86) 91 (1
Surgical abortion 
No 523 (60.25) 579 (6
Yes 345 (39.75) 310 (3
Gynecologic history
Previous EP 
No 736 (81.78) 869 (9
Yes 164 (18.22) 20 (2
Previous PID 
No 696 (79.36) 836 (9
Yes 119 (13.57) 29 (3
Unsure 62 (7.07) 11 (1
Serum chlamydia trachomatis IgG antibody 
Negative 384 (43.29) 743 (8
Positive 503 (56.71) 112 (1
Endometriosis 
No 842 (94.39) 863 (9
Yes 50 (5.61) 26 (2
Surgical history
Previous cesarean sectionc
No 113 (57.65) 118 (5
Yes 83 (42.35) 98 (4
Previous adnexal surgery 
No 662 (73.56) 853 (9
Yes 238 (26.44) 36 (4
Speciﬁc surgery 
No 662 (73.56) 853 (9
Ovarian surgery 30 (3.33) 13 (1
Surgery for ectopic pregnancy 111 (12.33) 11 (1
Surgery for tubal infertility 77 (8.56) 9 (1
Othersd 20 (2.22) 3 (0
Previous appendectomy 
No 855 (95.53) 862 (9
Yes 40 (4.47) 21 (2
EP: ectopic pregnancy; IUP: intrauterine pregnancy; OR: odds ratio; CI: conﬁdence int
a The sum does not necessarily equal the sample size for all variables because of the m
PID: 23 in cases and 13 in controls; CT IgG tests: 13 in cases and 34 in controls; endo
b The p value of the test for trend is given.
c The number of women having given birth (196 women in case group and 216 wo
d Other surgery including tubal infertility surgery combined with ovarian surgery and
tubal sterilization and (or) reversal of tubal sterilization; there are 3 cases of tubal sterili
sterilization, 3 of them belong to EP group, another 2 cases are in the IUP group.trend test was applied to study the difference between the two
groups. Odds ratios with 95% conﬁdence intervals were
calculated using univariable conditional logistic regression
analysis. Variables associated with EP by univariate analysis
were included as candidates in the multivariable logistic
regression model by stepwise selection. p-Values were estimat-
ed by two-sided tests. Statistical signiﬁcance was set at a p-
value of less than 0.05.
Results
During the study period, a total of 2416 women with EP were
interviewed, 915 of whom had planned pregnancy. A total of 912ectopic vs. intrauterine).
OR 95% CI p-Value
0.25
5.70) Reference
3.06) 0.87 [0.70, 1.10]
.24) 1.55 [0.72, 3.33]
<103 b
2.76) Reference
0.48) 1.43 [1.14, 1.78]
2.04) 2.43 [1.84, 3.22]
.72) 4.02 [2.74, 5.88]
0.01
2.01) Reference
.99) 1.53 [1.12, 2.11]
<103
9.76) Reference
0.24) 1.53 [1.15, 2.04]
0.03
5.13) Reference
4.87) 1.23 [1.02, 1.50]
<103
7.75) Reference
.25) 9.68 [6.02, 15.56]
<103
5.43) Reference
.31) 4.93 [3.24, 7.49]
.26) 6.77 [3.54, 12.95]
<103
6.90) Reference
3.10) 8.69 [6.84, 11.04]
0.01
7.08) Reference
.92) 1.97 [1.22, 3.20]
0.54
4.63) Reference
5.37) 1.13 [0.77, 1.67]
<103
5.95) Reference
.05) 8.52 [5.91, 12.27]
<103
5.95) Reference
.46) 2.97 [1.54, 5.75]
.24) 13.00 [6.94, 24.36]
.01) 11.02 [5.49, 22.15]
.34) 8.59 [2.54, 29.03]
0.02
7.62) Reference
.38) 1.92 [1.12, 3.28]
erval; PID: pelvic inﬂammatory disease.
issing data (parity: 32 in cases; number of previous abortion: 32 in cases; previous
metriosis: 8 in cases; previous appendectomy: 5 in cases and 6 in controls).
men in control group) was used as the denominator to calculate the percentage.
 (or) tubal ectopic pregnancy surgery and (or) tubal reconstructive surgery and (or)
zation, all 3 cases belong to EP group; there are 5 cases undergone reversal of tubal
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control group. Women later withdrawing from the study or
providing incomplete information were excluded. Out of 1827
women with planned pregnancies, a total of 900 ﬁnal cases (EP
group) and 889 controls (IUP group) were included into the study
with a response rate of 97.92% (recruitment proﬁle shown in
Fig. 1).
Univariable analysis
Because of the matching criteria employed in this study, there
was no signiﬁcant difference in age (p = 0.29) between the two
groups (Table 1). Women with lower educational attainment
(ptrend < 10
3), or lower annual income (ptrend < 10
3), or unem-
ployed/self-employed women (p < 103) were more likely to have
an EP (Table 1). Moreover, the impact of tobacco exposure on the
EP risk displayed a dose-dependent correlation (OR = 1.60 and
2.79, ptrend < 10
3, Table 1). Women with a history of previous
abortion (spontaneous, medical, or surgical), previous EP, previous
PID, previous adnexal surgery, previous appendectomy, or positive
reactivity to CT IgG antibody were more likely to have an EP as
compared to those without these factors (Table 2). Notably, from
among 164 cases and 20 controls with previous EP, 53.05% (87/
164) of the cases and 45.00% (9/20) of the controls received
unilateral salpingectomy, and 14.63% of the (24/164) cases and
10.00% (2/20) of the controls received salpingostomy. Further-
more, from among a total of 274 women in both groups withTable 3
Previous contraceptive use in women with planned pregnancy (ectopic vs. intrauterine
EP IUP 
na (%) na (%)
Previous experience
Condom 
No 395 (43.89) 137 (15.41) 
Yes 505 (56.11) 752 (84.59) 
Calendar rhythm method 
No 801 (89.00) 797 (89.65) 
Yes 99 (11.00) 92 (10.35) 
Withdrawal method 
No 821 (91.22) 811 (91.23) 
Yes 79 (8.78) 78 (8.77) 
Tubal ligationc
No 894 (99.33) 887 (99.78) 
Yes 6 (0.67) 2 (0.22) 
Emergency contraceptive pills 
No 574 (64.71) 527 (59.35) 
Yes 313 (35.29) 361 (40.65) 
Oral contraceptive pills 
No 864 (96.00) 859 (96.63) 
Yes 36 (4.00) 30 (3.37) 
IUD 
No 801 (89.00) 827 (93.03) 
Yes 99 (11.00) 62 (6.97) 
Duration of previous IUD use (years) 
Never 801 (89.00) 827 (93.03) 
<1 7 (0.87) 12 (1.35) 
1–2 37 (4.11) 22 (2.47) 
3 55 (6.11) 28 (3.15) 
Intercourse frequency
(times per month)d
1 226 (25.34) 181 (21.02) 
2–4 321 (35.99) 302 (35.08) 
5 345 (38.68) 378 (43.90) 
EP: ectopic pregnancy; IUP: intrauterine pregnancy; OR: odds ratio; CI: conﬁdence int
a The sum does not necessarily equal the sample size for all variables because of miss
frequency: 8 in cases and 28 in controls).
b The p value of the test for trend is given.
c There were three women having received tubal sterilization, and all of them wer
sterilization, three of whom were in the EP group and the rest two were in the IUP gr
d Average times of sexual intercourse per month during the past six months.adnexal surgical therapy, 32.35% (77/238) of the cases and 25.00%
(9/36) of the controls were treated for infertility.
The results (Table 3) showed that the use of condoms could be a
protective factor for EP in the current cycle (OR = 0.23, 95% CI:
0.19–0.29). However, previous use of the intrauterine device (IUD)
increased the risk of EP in the current cycle (OR = 1.65, 95% CI:
1.18–2.30). The trend test showed a statistical signiﬁcance
between the duration of past IUD use and EP risk (ptrend < 10
3).
Based on these results (Table 4), tubal factor infertility had a
higher OR of 8.81 (95% CI: 6.33–12.25) as compared to that of any
of the non-tubal factor (OR = 5.82, 95% CI: 3.47–9.78) and
combined factor (OR = 5.39, 95% CI: 3.11–9.36) infertilities. About
65.33% (309/473) of the infertile women from both groups were
diagnosed with tubal factor infertility, and the proportion of
women with tubal factor infertility in the case group was much
higher than that of the control group (29.11% vs. 5.29%). The trend
test found statistical signiﬁcance in the association between
infertility duration and EP risk (ptrend < 10
3). Women who had
ever received hysterosalpingography were more likely as com-
pared to those with none to have an EP in the current cycle
(OR = 6.95, 95% CI: 5.21–9.28). Irrespective of the type, women
with a history of tubal cannulation treatment were more likely to
have an EP in the current cycle (OR = 7.93, 95% CI: 5.72–11.00) as
compared to those with no treatment history. Furthermore, the EP
risk increased with a signiﬁcant trend as the number of tubal
cannulation treatments increased (OR = 6.82–14.39, ptrend < 10
3).
About 46% (61/132) of the women in the case group had received).
OR 95% CI p-Value
<103
Reference
0.23 [0.19, 0.29]
0.66
Reference
1.07 [0.79, 1.45]
1.00
Reference
1.00 [0.72, 1.39]
0.18
Reference
2.97 [0.60, 14.74]
0.02
Reference
0.80 [0.66, 0.97]
0.48
Reference
1.19 [0.73, 1.95]
<102
Reference
1.65 [1.18, 2.30]
<103 b
Reference
0.60 [0.24, 1.54]
1.74 [1.02, 2.97]
2.03 [1.27, 3.23]
0.04
Reference
0.85 [0.66, 1.09]
0.73 [0.57, 0.93]
erval; IUD: intrauterine device.
ing data (emergency contraceptive pills: 13 in cases and 1 in controls; intercourse
e in the EP group. There were ﬁve women having experienced reversal of tubal
oup.
Table 4
History of infertility in women with planned pregnancy (ectopic vs. intrauterine).
EP IUP OR 95% CI p-Value
na (%) na (%)
History of infertility <103
No 510 (56.67) 806 (90.66) Reference
Tubal infertility 262 (29.11) 47 (5.29) 8.81 [6.33, 12.25]
Non-tubal infertility 70 (7.78) 19 (2.14) 5.82 [3.47, 9.78]
Combined infertilityc 58 (6.44) 17 (1.91) 5.39 [3.11, 9.36]
Duration of infertility (years) <103 b
No infertile history 510 (56.79) 806 (90.66) Reference
1 130 (14.48) 51 (5.74) 4.03 [2.86, 5.67]
2 115 (12.81) 17 (1.91) 10.69 [6.35, 18.00]
3 143 (15.92) 15 (1.69) 15.07 [8.75, 25.94]
Hysterosalpingography <103
No 576 (64.57) 811 (92.69) Reference
Yes 316 (35.43) 64 (7.31) 6.95 [5.21, 9.28]
Tubal cannulation for infertility <103
No 606 (69.02) 831 (94.65) Reference
Yes 272 (30.98) 47 (5.35) 7.93 [5.72, 11.00]
Number of tubal cannulation treatment <103 b
0 606 (69.02) 831 (94.65) Reference
1 184 (20.96) 37 (4.21) 6.82 [4.72, 9.86]
2 67 (7.63) 8 (0.91) 11.48 [5.48, 24.00]
3 21 (2.39) 2 (0.23) 14.39 [3.36, 61.64]
Methods of tubal cannulation <103
None 606 (69.02) 831 (94.65) Reference
Therapeutic hydrotubation 104 (11.85) 10 (1.14) 14.26 [7.39, 27.52]
HTC 67 (7.63) 14 (1.59) 6.56 [3.66, 11.78]
SSG combined with HTC 60 (6.83) 19 (2.16) 4.33 [2.56, 7.33]
Laparoscopical salpingoplasty and laparoscopy guided HTC 41 (4.67) 4 (0.46) 14.06 [5.00, 39.45]
ART applied in the current cycle of conception <103
Spontaneous pregnancy 765 (85.28) 844 (96.13) Reference
Ovarian stimulation 18 (2.01) 5 (0.57) 3.97 [1.47, 10.75]
Intrauterine insemination 7 (0.78) 1 (0.11) 7.72 [0.95, 62.91]
In vitro fertilization 61 (6.80) 3 (0.34) 22.43 [7.01, 71.79]
Chinese herb 22 (2.45) 12 (1.37) 2.02 [0.99, 4.11]
Luteal phase support 6 (0.67) 4 (0.46) 1.65 [0.47, 5.88]
Combination of ovarian stimulation and luteal phase support 18 (2.01) 9 (1.03) 2.21 [0.98, 4.94]
EP: ectopic pregnancy; IUP: intrauterine pregnancy; OR: odds ratio: CI: conﬁdence interval; HTC: hysteroscopical tubal catheterization and (or) cannulation; SSG: selective
salpingography; ART: assisted reproduction technology.
a The sum does not necessarily equal the sample size for all variables because of missing data (duration of infertility: 2 in cases; hysterosalpingography: 8 in cases and 14 in
controls; tubal cannulation for infertility: 22 in cases and 11 in controls; number of tubal cannulation treatment: 22 in cases and 11 in controls; Methods of tubal cannulation:
22 in cases and 11 in controls; ART applied in the current cycle of conception: 3 in cases and 11 in controls).
b The p value of the test for trend is given.
c Combined infertility stand for multiple factors including tubal and non-tubal factors that contribute to infertility.
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times those in the control group (8.82%, 3/34). Among 64 women
who received IVF treatment, most of them (60/64, 93.75%) had
tubal infertility, with only four (6.25%) suffering from non-tubal
infertility. Most of the women with non-tubal infertility (53/89,
59.55%) got pregnant naturally without ART.
Multivariable analysis
The signiﬁcantly different factors between the two groups were
revealed by univariable analysis and were entered into a multiple
logistic regression model in order to detect the risk factors for EP in
women with planned pregnancy (Table 5). Compared to women
with no PID history, the chance of having an EP was higher in
women who claimed a previous PID with an adjusted OR (AOR) of
2.17 (95% CI: 1.28–3.68), and much higher in women who were
uncertain if they had ever had PID (AOR = 6.89, 95% CI: 3.29–
14.41). In our study, the previous PID was claimed by the
participants themselves. As a result, a few women (62 in the case
and 11 in the control groups) were unsure if they had ever had PID.
To ensure the results were reliable, all the participants received a
serology CT IgG screening test as an indicator of a previous PID
with a sensitivity of 72.4% and a speciﬁcity of 92.6% [9]. It appeared
that the risk of EP in women with detectable CT IgG was about ﬁve
times of those with negative reaction (95% CI: 3.94–7.04).Compared to those without previous adnexal surgery, women
with a previous experience of adnexal surgery were more likely to
have an EP in the current cycle (AOR = 3.99, 95% CI: 2.40–6.63). A
history of infertility was another risk factor for EP in women with
planned pregnancy (tubal infertility: AOR = 3.62, 95% CI: 1.52–
8.63; non-tubal infertility: AOR = 3.34, 95% CI: 1.60–6.93). In
women who received ART during the current cycle, those receiving
IVF treatment had a higher risk of EP (AOR = 5.96, 95% CI: 1.68–
21.21) than those treated with other ART. Previous condom use
signiﬁcantly reduced the risk of EP in the current cycle (AOR = 0.27,
95% CI: 0.21–0.36). Our ﬁnal multivariable logistic regression
analysis did not ﬁnd any association between a previous EP and the
risk of a current EP (AOR = 1.73, 95% CI: 0.93–3.23).
Comments
Nearly 9% of all pregnancy-related maternal deaths and 75% of
the maternal deaths during the ﬁrst trimester can be attributed to
EP [1]. Ectopic pregnancy and its emergency complications do
physical and psychological harm to women as well as straining
emergency medical resources [10]. We designed this case–
control study, tracing backwards from outcome to exposure, in
order to study the EP risk factors in women with planned
pregnancy with the hope of providing advice on primary EP
prevention.
Table 5
Multivariable logistic regression analysis of risk factors for EP in women with
planned pregnancy (ectopic vs. intrauterine).a
Adjusted OR 95% CI
Serum chlamydia trachomatis IgG antibody
Negative Reference
Positive 5.26 [3.94, 7.04]
Previous PID
No Reference
Yes 2.17 [1.28,3.68]
Unsure 6.89 [3.29, 14.41]
Previous EP
No Reference
Yes 1.73 [0.93, 3.23]
Previous adnexal surgery
No Reference
Yes 3.99 [2.40, 6.63]
Previous condom use
No Reference
Yes 0.27 [0.21, 0.36]
Infertility
No Reference
Tubal infertility 3.62 [1.52, 8.63]
Non-tubal infertility 3.34 [1.60, 6.93]
Combined infertilityb 3.19 [1.04, 9.78]
ART applied in the current cycle of conception
Spontaneous pregnancy Reference
Ovarian stimulation 0.94 [0.26, 3.40]
Intrauterine insemination 2.71 [0.27, 27.83]
In vitro fertilization 5.96 [1.68, 21.21]
Chinese herb 0.57 [0.22, 1.48]
Luteal phase support 0.61 [0.11, 3.45]
Combination of ovarian stimulation
and luteal phase support
0.82 [0.25, 3.45]
EP: ectopic pregnancy; IUP: intrauterine pregnancy; OR: odds ratio: CI: conﬁdence
interval; PID: pelvic inﬂammatory disease; ART: assisted reproduction technology.
a Stepwise selection, slentry = 0.10, slstay = 0.15.
b Combined infertility stand for multiple factors including tubal and non-tubal
factors that contribute to infertility.
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an associated OR of up to 7.5 [11–13], with about one third of the
EP occurrence being relevant to PID [14]. Genitourinary CT
infection was reported as a major PID pathogen and up to 60%
of the patients with salpingitis had a positive reaction to the CT
serology IgG test [15]. It is estimated that 80–90% of women with
genitourinary CT infection are asymptomatic or have subclinical
infection with approximately 30% who might develop PID if left
untreated [16]. Compared to those with negative results, women
with detectable CT IgG were more likely to have an EP in their
current cycle. We suggest that a lower genital tract CT infection
could ascend into the upper reproductive tract resulting in
salpingitis. With a local inﬂammatory response and tubal structural
abnormality caused by salpingitis, tubal implantation is more likely
to occur [17]. Furthermore, CT infection decreases the activity of the
tubal epithelium cilia and the contraction of the tubal smooth
muscle, which substantially increases the risk of EP [2,5].
Consistent with the previous ﬁndings [18,19], previous abortion
did not pose a risk for EP as revealed by the multivariable analysis,
despite the signiﬁcant ORs in the univariable analysis. About half of
the participants had had induced abortion (including medical or
surgical induction) in our study. Furthermore, we observed that
poor-hygienic abortions might increase the risk of post-abortal
infections, which could lead to EP [20]. A legal and hygienic
abortion, however, did not carry a large excess risk for future EP
[19]. Although of only borderline signiﬁcance in the ﬁnal logistic
regression analysis, there was a possibility for fallopian tube tissue
remodeling after the surgical treatment of previous EP (including
salpingostomy and salpingectomy). This could in turn result in
tubal stenosis or even blockage, and ﬁnally an increased chance ofa recurrent EP [2,21]. In terms of IUD and the duration of its use in
our study, although it showed a positive trend of association with
EP, it was not conﬁrmed as a risk factor by multivariable analysis.
According to the ACOG guideline, previous use of an IUD does not
appear to increase the absolute risk of EP, because IUD can
effectively prevent pregnancy [22]. In addition, previous condom
use could reduce the risk of EP because a barrier contraceptive
method could reduce the chance of sexually transmitted infections
and subsequent risk of PID with associated sequelae [23].
Being a planned, rather than unplanned, pregnancy could have
an impact on the pregnancy outcome. Infertile women, unable to
become pregnant after one year of trying, are often referred to ART
to increase their chance of conception; meanwhile, their chance of
having an EP is increased. It is estimated that the incidence of EP
following ART varies from 2.1% to 8.6% of all pregnancies and
reaches 11% in women with tubal infertility, which is approxi-
mately 2.5–5 fold higher than EP rate occurred in natural
conceptions [24,25]. In our study, a history of infertility, especially
tubal factor infertility, was strongly correlated to the occurrence of
EP in the current cycle, which has been well documented in the
literature [14,26]. It has been acknowledged that IVF is a valuable
treatment for infertility, especially tubal infertility, but cases of EP
were also reported following IVF treatment. The ﬁrst pregnancy
conceived following IVF treatment, reported in 1976, ended up as a
tubal EP [27]. An epidemiologic study from Turkey proposed that
IVF could increase the risk of EP with an OR up to 14.8 [28].
However, the reason for the risk of EP following IVF is unclear.
Many potential causes, including: hormonal milieu change, a lack
of ultrasound guided embryo transfer, and multiple number of
embryos transfer, might contribute to the occurrence of EP [24].
Although this study reported an adjusted OR of about 6 for the
post-IVF EP, this does not account for the overall increased risk
of post-IVF EP for its relative wider conﬁdence interval.
Notably, most women who received IVF treatment had tubal-
factor infertility in this study. Tubal damage, usually resulting
from surgical procedures, tubal infection, or previous EP, might
contribute to a higher rate of EP occurrence among these
women who received IVF treatment [2,29]. Our study reported
that 60 out of the 64 women with tubal-factor infertility had
previously undergone surgical procedures, including tubal
cannulation and tubal reconstructive microsurgery, before
the IVF treatment. Therefore, the increased risk of EP in women
with IVF treatment might be mainly attributed to the tubal-
factor infertility or surgical procedures rather than the IVF
itself. Additionally, our ﬁndings also showed that non-tubal
infertility increased the risk of EP. However, due to the small
number of women with non-tubal infertility becoming preg-
nant with ART, this study could hardly explore whether ART
inﬂuenced the risk of EP or not. Therefore, further study should
be conducted.
The present study had other limitations as well. Due to
individual privacy, information bias could be hardly avoided, but
we used some objective evidence, such as CT antibody tests and
medical records, to improve the reliability. Investigators also failed
to get some information, such as whether participants were in
monogamous relationships instead of marital status as a study
factor. Another concern was the conﬁrmation of PID. About 10% of
asymptomatic or subclinical PID is due to etiologies other than CT
[16].
We demonstrated that besides EP risk factors, including genital
CT infection, previous PID, and previous adnexal surgery, attention
should be paid toward women planning pregnancy who have a
history of infertility and IVF treatment, particularly tubal infertility
cases. This could beneﬁt professional health care providers in
optimizing the medical services in order to prevent the occurrence
of EP among this population when providing ART.
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